Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Ascendis Pharmac(ASND) the Revenue is 387.67 M (+109.6%), Beat estimate;the EBIT is 251.9 M (+506.4%), Beat estimate;the EPS is 3.23 (+531.6%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.39B109.55%
0.38B103.76%
+0.01B5.79%
EBITExceed expectations
0.25B506.41%
0.09B248.32%
+0.16B258.09%
EPSExceed expectations
3.2335531.63%
1.5856311.65%
+1.6479219.98%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf